Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies
Clinical trial NCT03443674 · COMPLETED
Trial details
- NCT number
- NCT03443674
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2021-05-30
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.